Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Engineers have developed 3D-printable miniature "fish" that may be capable of propelling themselves through blood vessels and delivering drugs to specific cells.
In a recent study comparing the healing properties of the current standard of care, EpiFix, and Apligraf on persistent diabetic foot wounds, EpiFix, a dehydrated human amnion/chorion membrane…
If your inner trekkie (or trekker) yearns for Star Trek technology in the present day, Scanadu might be paving the way for healthcare's first "tricorder"-like device.
David Ahn, MD, endocrinologist and founder of Sugar Streak, breaks down how and why smart devices are transforming healthcare. Given the boring and rather burdensome nature of recording…
